Agilent IQFISH Lung Cancer Panel

Agilent Technologies has launched its IQFISH lung cancer panel for automated analysis on Dako Omnis in Europe with a CE-IVD mark. The panel comprises ALK, ROS1, RET, and MET IQFISH probes, andwas designed using oligonucleotide-based SureFISH technology with formamide-free IQFISH fast hybridization buffer. The panel allows labs to simultaneously stain IHC and FISH slides and enable multiple FISH slides to be processed in just four hours, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.